The US Immunotherapy Drugs Market represents the largest share of the global market, driven by a high prevalence of cancer and autoimmune disorders, substantial healthcare spending, and strong investments in biopharmaceutical research and development. The country is home to many leading pharmaceutical and biotechnology companies actively developing innovative immunotherapy treatments, including...